GNLX
GNLX
NASDAQ · Biotechnology

Genelux Corp

$1.96
+0.14 (+7.69%)
Analyst Consensus
Strong Buy
11
Analysts
Moderate
Coverage
Buy 10 91%
Hold 1 9%
Sell 0 0%
Price Target
Analyst Price Target +174.0% upside
Low Target $3.28
Average Target $5.37
High Target $6.50
Current Price $1.96
Current
$1.96
Target
$5.37
$3.28 $5.37 avg $6.50
Scenario Analysis
Bear Case
$3.28
67.3%
Low target
Base Case
$5.37
+174.0%
Avg target
Bull Case
$6.50
+231.6%
High target
Risk/Reward
3.4x
Highly favorable
Price in Context
52-Week High
$8.54
-77.0% from high
52-Week Low
$1.77
+10.7% from low
Target vs 52W High
$5.37
-37.1% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -12.5%
AMGN
Amgen Inc
Hold 42 43% $190.87 -59.0%
GILD
Gilead Sciences Inc
Strong Buy 36 83% $362.68 +115.4%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -18.5%
MRNA
Moderna Inc
Hold 31 32% $149.45 -35.4%
REGN
Regeneron Pharmaceuticals
Buy 36 72% $76.80 -92.0%
NTRA
Natera Inc
Strong Buy 31 90% $142.91 -55.7%
RVMD
Revolution Medicines Inc
Strong Buy 31 94% $114.11 -35.3%